Bettina M. Goricke
Hannover, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Minimum important slowing of disease progression as determined by the ALS functional rating scale - a survey of patient expectations toward disease-modifying drugs in ALS.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: January 20, 2026
Dextromethorphan/quinidine (DMQ) for reducing bulbar symptoms in amyotrophic lateral sclerosis - assessment of treatment experience in a multicenter study.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: September 11, 2025
Shared prognostic information in amyotrophic lateral sclerosis - systematic assessment of the patients' perception of neurofilament light chain and the ALS functional rating scale.
Journal: Neurological research and practice
Published: October 19, 2024
In-depth analysis of data from the RAS-ALS study reveals new insights in rasagiline treatment for amyotrophic lateral sclerosis.
Journal: European journal of neurology
Published: June 30, 2023
Dysphagia in amyotrophic lateral sclerosis: Quantification of bulbar motor dysfunction.
Journal: Journal of oral rehabilitation
Published: February 01, 2021
Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.
Journal: The Lancet. Neurology
Published: February 28, 2018
Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies.
Journal: Acta neuropathologica
Published: July 24, 2015
Pegylated granulocyte colony-stimulating factor conveys long-term neuroprotection and improves functional outcome in a model of Parkinson's disease.
Journal: Brain : a journal of neurology
Published: March 20, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026